$0.651 (-2.98%)

Volume: 52.693k

Closed: Jan 27, 2023

Hollow Logo Score: 1.931
Galmed Pharmaceuticals Ltd. Stock
$0.651 (-2.98%)

Volume: 52.693k

Closed: Jan 27, 2023

Score Hollow Logo 1.931
NASDAQ:GLMD

Galmed Pharmaceuticals Ltd. Stock Price (Quote)

$0.651 ( -2.98% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $0.405 $0.95 Friday, 27th Jan 2023 GLMD stock ended at $0.651. This is 2.98% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 10.63% from a day low at $0.650 to a day high of $0.719.
90 days $0.290 $0.95
52 weeks $0.290 $1.84

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
2023-01-27 $0.661 $0.719 $0.650 $0.651 52 693
2023-01-26 $0.656 $0.690 $0.635 $0.671 64 609
2023-01-25 $0.690 $0.712 $0.630 $0.640 102 941
2023-01-24 $0.700 $0.757 $0.690 $0.707 68 899
2023-01-23 $0.730 $0.760 $0.682 $0.716 64 648
2023-01-20 $0.741 $0.772 $0.700 $0.751 85 625
2023-01-19 $0.700 $0.741 $0.652 $0.700 67 900
2023-01-18 $0.700 $0.781 $0.650 $0.700 207 534
2023-01-17 $0.770 $0.83 $0.698 $0.731 379 612
2023-01-13 $0.82 $0.86 $0.716 $0.80 233 927
2023-01-12 $0.89 $0.90 $0.80 $0.81 100 900
2023-01-11 $0.94 $0.94 $0.87 $0.88 37 954
2023-01-10 $0.85 $0.95 $0.85 $0.90 279 339
2023-01-09 $0.799 $0.85 $0.790 $0.83 227 139
2023-01-06 $0.81 $0.82 $0.750 $0.80 117 420
2023-01-05 $0.742 $0.84 $0.732 $0.80 144 456
2023-01-04 $0.791 $0.85 $0.750 $0.777 361 517
2023-01-03 $0.673 $0.720 $0.520 $0.711 436 442
2022-12-30 $0.460 $0.524 $0.450 $0.500 60 723
2022-12-29 $0.405 $0.530 $0.405 $0.460 329 902
2022-12-28 $0.500 $0.540 $0.472 $0.472 221 989
2022-12-27 $0.587 $0.587 $0.479 $0.540 169 705
2022-12-23 $0.590 $0.630 $0.502 $0.538 253 274
2022-12-22 $0.450 $0.640 $0.450 $0.590 640 558
2022-12-21 $0.304 $0.550 $0.301 $0.451 1 510 147
2022-12-20 $0.290 $0.320 $0.290 $0.310 207 378
2022-12-19 $0.300 $0.362 $0.296 $0.340 727 636
2022-12-16 $0.300 $0.300 $0.290 $0.290 109 550
2022-12-15 $0.300 $0.300 $0.290 $0.290 36 910
2022-12-14 $0.290 $0.300 $0.290 $0.300 50 021
2022-12-13 $0.301 $0.310 $0.290 $0.299 80 416
2022-12-12 $0.307 $0.319 $0.290 $0.310 200 168
2022-12-09 $0.300 $0.317 $0.290 $0.290 63 138
2022-12-08 $0.290 $0.311 $0.290 $0.290 27 302
2022-12-07 $0.305 $0.305 $0.290 $0.295 46 057
2022-12-06 $0.305 $0.305 $0.291 $0.294 35 678
2022-12-05 $0.290 $0.319 $0.290 $0.317 15 025
2022-12-02 $0.300 $0.319 $0.300 $0.306 7 483
2022-12-01 $0.300 $0.306 $0.291 $0.300 44 827
2022-11-30 $0.293 $0.308 $0.290 $0.292 20 166
2022-11-29 $0.298 $0.319 $0.290 $0.298 40 870
2022-11-28 $0.300 $0.329 $0.298 $0.320 15 273
2022-11-25 $0.310 $0.330 $0.300 $0.300 28 443
2022-11-23 $0.320 $0.337 $0.300 $0.301 33 231
2022-11-22 $0.330 $0.340 $0.320 $0.321 18 741
2022-11-21 $0.322 $0.340 $0.320 $0.320 24 082
2022-11-18 $0.328 $0.340 $0.320 $0.327 3 431
2022-11-17 $0.330 $0.340 $0.321 $0.330 24 403
2022-11-16 $0.340 $0.340 $0.321 $0.336 8 060
2022-11-15 $0.314 $0.340 $0.314 $0.330 45 827

Hot Stocks To Watch:

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT